Cholesterol metabolism after bariatric surgery in grade 3 obesity: Differences between malabsorptive and restrictive procedures

Diabetes Care

Volumn 36, Issue 6, 2013, Pages 1443-1447

  Benetti, Alberto ^a,b   Del Puppo, Marina ^c   Crosignani, Andrea ^a,b   Veronelli, Annamaria ^a,b   Masci, Enzo ^a,b   Frigè, Francesca ^a,b   Micheletto, Giancarlo ^a,d   Panizzo, Valerio ^d   Pontiroli, Antonio E ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d ISTITUTO CLINICO SANT'AMBROGIO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; CAMPESTEROL; CHOLESTEROL; GLUCOSE; INSULIN; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITOSTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MALABSORPTION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; SURGICAL TECHNIQUE; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 84878243809     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1737     Document Type: Article

References (20)

1. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009;19:1605-1611
2. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis. Am J Med 2009;122:248-256, e5
3. Doldi SB, Lattuada E, Zappa MA, Pieri G, Restelli A, Micheletto G. Biliointestinal bypass: another surgical option. Obes Surg 1998;8:566-569 (Pubitemid 29004799)
4. Buchwald H, Rudser KD, Williams SE, Michalek VN, Vagasky J, Connett JE. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias. Ann Surg 2010;251:1034-1040
5. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-1737 (Pubitemid 39346675)
6. Pontiroli AE, Laneri M, Veronelli A, et al. Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol 2009;8:37
7. Frige' F, Laneri M, Veronelli A, et al. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 2009;19:198-204
8. Pontiroli AE, Pizzocri P, Librenti MC, et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 2002;87:3555-3561 (Pubitemid 34879496)
9. Del Puppo M, Crosignani A, Longo M, et al. A minimally invasive technique for the evaluation of the regulatory steps of the two major pathways of bile acid synthesis. Clin Chim Acta 2005;355:23-31
10. Nissinen MJ, Gylling H, Miettinen TA. Effects of dietary cholesterol and fat on serum non-cholesterol sterols according to different apolipoprotein E subgroups among healthy men. Br J Nutr 2008;100:373-379
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations inman. Diabetologia 1985;28:412-419 (Pubitemid 15018832)
14. Del Puppo M, Kienle MG, Petroni ML, Crosignani A, Podda M. Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway. J Lipid Res 1998;39:2477-2482 (Pubitemid 29006312)
15. Ciuffreda P, Casati S, Alessandrini L, Terraneo G, Santaniello E. Synthesis of deuterated isotopomers of 7α- and (25R,S)-26- hydroxycholesterol, internal standards for in vivo determination of the two biosynthetic pathways of bile acids. Steroids 2003;68:733-738 (Pubitemid 37414812)
16. Javitt NB, Kok E, Lloyd J, Benscath A, Field FH. Cholest-5-ene-3 beta, 26-diol: synthesis and biomedical use of a deuterated compound. Biomed Mass Spectrom 1982;9:61-63 (Pubitemid 12153721)
17. Duane WC, Javitt NB. 27-hydroxycholesterol: production rates in normal human subjects. J Lipid Res 1999;40:1194-1199 (Pubitemid 29328522)
18. Corradini SG, Eramo A, Lubrano C, et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 2005;15:367-377 (Pubitemid 40463605)
19. Repa JJ, Mangelsdorf DJ. Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr Opin Biotechnol 1999;10:557-563
20. Bays HE. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res 2004;12:1197-1211 (Pubitemid 41137461)